Evidence map›Paper›PMID 27070147›Full record

ArticlePloS one2016

Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress.

Luiza A Rabelo, Mihail Todiras, Valéria Nunes-Souza, Fatimunnisa Qadri, István András Szijártó, Maik Gollasch, Josef M Penninger, Michael Bader, Robson A Santos, Natalia Alenina

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Unlocking Implantation: The Role of Nitric Oxide, NOInternational journal of molecular sciences · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Alternative Renin-Angiotensin System.Hypertension (Dallas, Tex. : 1979) · 2024
    Review
  9. Review
  10. The RAAS Goodfellas in Cardiovascular System.Journal of clinical medicine · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. The role of angiotensin-converting enzyme 2 (The Egyptian journal of medical human genetics · 2022
    Review
  17. Review
  18. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  19. Association ofFrontiers in cardiovascular medicine · 2022
    Article
  20. ACE2: a key modulator of the renin-angiotensin system and pregnancy.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Luiza A RabeloMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Mihail TodirasMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Valéria Nunes-SouzaMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Fatimunnisa QadriMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
István András SzijártóNephrology/Intensive Care, Charité Campus Virchow Klinikum, Experimental and Clinical Research Center (ECRC), Berlin, Germany.
Maik GollaschNephrology/Intensive Care, Charité Campus Virchow Klinikum, Experimental and Clinical Research Center (ECRC), Berlin, Germany.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Michael BaderMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Robson A SantosInstituto Nacional de Ciência e Tecnologia em NanoBiofarmacêutica (NanoBIOFAR).
Natalia AleninaMax-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEMax Delbrück Center · DEUniversidade Federal de Minas Gerais · BRInstitute of Molecular Biotechnology · ATUniversidade Federal de Alagoas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates that angiotensin-converting enzyme 2 (ACE2) plays a critical role in cardiovascular homeostasis, and its altered expression is associated with major cardiac and vascular disorders. The aim of this study was to evaluate the regulation of vascular function and assess the vascular redox balance in ACE2-deficient (ACE2-/y) animals. Experiments were performed in 20-22 week-old C57BL/6 and ACE2-/y male mice. Evaluation of endothelium-dependent and -independent relaxation revealed an impairment of in vitro and in vivo vascular function in ACE2-/y mice. Drastic reduction in eNOS expression at both protein and mRNA levels, and a decrease in •NO concentrations were observed in aortas of ACE2-/y mice in comparison to controls. Consistently, these mice presented a lower plasma and urine nitrite concentration, confirming reduced •NO availability in ACE2-deficient animals. Lipid peroxidation was significantly increased and superoxide dismutase activity was decreased in aorta homogenates of ACE2-/y mice, indicating impaired antioxidant capacity. Taken together, our data indicate, that ACE2 regulates vascular function by modulating nitric oxide release and oxidative stress. In conclusion, we elucidate mechanisms by which ACE2 is involved in the maintenance of vascular homeostasis. Furthermore, these findings provide insights into the role of the renin-angiotensin system in both vascular and systemic redox balance.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsAntioxidantsAortaEndothelium, VascularFemaleGene DeletionLipid PeroxidationMaleMiceMice, Inbred C57BLNitric OxideNitric Oxide Synthase Type IIIOxidation-ReductionOxidative StressPeptidyl-Dipeptidase AAce2 protein, mouseAngiotensin-Converting Enzyme 2AntioxidantsNitric OxideNitric Oxide Synthase Type IIINos3 protein, mousePeptidyl-Dipeptidase ARNA, MessengerSuperoxide Dismutase

Identifiers

PMID27070147
PMCPMC4829150
OpenAlexW2337247222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.